Portage Biotech Inc PRTG:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:55 PM EDT
8.15quote price arrow up+0.01 (+0.12%)
Volume
1,504
Close
8.14quote price arrow up+1.52 (+22.96%)
Volume
59,615
52 week range
4.62 - 44.98
Loading...
  • Open6.90
  • Day High8.63
  • Day Low6.77
  • Prev Close6.62
  • 52 Week High44.98
  • 52 Week High Date06/18/21
  • 52 Week Low4.62
  • 52 Week Low Date04/26/22

Key Stats

  • Market Cap108.67M
  • Shares Out13.35M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta-2.70
  • YTD % Change-24.14

KEY STATS

  • Open6.90
  • Day High8.63
  • Day Low6.77
  • Prev Close6.62
  • 52 Week High44.98
  • 52 Week High Date06/18/21
  • 52 Week Low4.62
  • 52 Week Low Date04/26/22
  • Market Cap108.67M
  • Shares Out13.35M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta-2.70
  • YTD % Change-24.14

RATIOS/PROFITABILITY

  • EPS (TTM)-1.69
  • P/E (TTM)-4.82
  • Fwd P/E (NTM)-7.03
  • EBITDA (TTM)-20.525M
  • ROE (TTM)-18.25%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Portage Biotech Inc

There is no recent news for this security.

Profile

MORE
Portage Biotech Inc. is a Canada-based clinical-stage immuno-oncology company. The Company is advancing therapies to improve long-term treatment response and quality of life in patients with evasive cancers. The Company’s access to technologies coupled with a deep understanding of biological mechanisms enables the identification of clinical therapies and product development strategies, which accelerate these medicines through the translational pipeline. The Company’s...
Gregory Bailey M.D.
Chairman of the Board
Ian Walters M.D.
Chief Executive Officer, Director
Allan Shaw
Chief Financial Officer
Address
47 Avenue Rd Suite 200
Toronto, ON
M5R 2G3
Canada

Top Peers

SYMBOLLASTCHG%CHG
IMV
IMV Inc
1.03-0.03-2.83%
CRDL
Cardiol Therapeutics Inc
1.14-0.03-2.56%
APS
CYBN
Cybin Inc
0.5905+0.0205+3.60%
ONC